Arena Pharmaceuticals
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, a Phase IIb/III clinical trial for Crohn's disease, and a Phase IIb clinical trial for atopic dermatitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; and APD418 that is in Phase I clinical trial for acute heart failure. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Beacon Discovery; Boehringer Ingelheim International GmbH; and Eisai Co., Ltd. and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.
Show more...
CEO
Amit Munshi
Employees
363
Country
United States
ISIN
US0400476075
Listings
0 Comments
Share your thoughts
FAQ
What is Arena Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Arena Pharmaceuticals stocks are traded under the ticker RN3N.STU.
How many employees does Arena Pharmaceuticals have?▼
As of September 04, 2026, the company has 363 employees.
In which sector is Arena Pharmaceuticals located?▼
Arena Pharmaceuticals operates in the Manufacturing sector.
When did Arena Pharmaceuticals complete a stock split?▼
Arena Pharmaceuticals has not had any recent stock splits.
Where is Arena Pharmaceuticals headquartered?▼
Arena Pharmaceuticals is headquartered in San Diego, United States.